PCC Rokita (WAR:PCR) Other Current Liabilities: zł169 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:PCR PCC Rokita SA WAR:PCR
82 GF Score
Price zł69.50
GF Value zł66.24
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PCC Rokita Other Current Liabilities?

PCC Rokita WAR:PCR +8.26% 82 Other Current Liabilities is zł169 Mil as of Mar. 2026. GuruFocus rates WAR:PCR with a GF Score™ of 82/100 and a GF Value™ of zł66.24 (Fairly Valued). The stock has 8 warning signs investors should review.

PCC Rokita's other current liabilities for the quarter that ended in Mar. 2026 was zł169 Mil.

PCC Rokita's quarterly other current liabilities increased from Sep. 2025 (zł147 Mil) to Dec. 2025 (zł155 Mil) and increased from Dec. 2025 (zł155 Mil) to Mar. 2026 (zł169 Mil).

PCC Rokita's annual other current liabilities declined from Dec. 2023 (zł205 Mil) to Dec. 2024 (zł184 Mil) and declined from Dec. 2024 (zł184 Mil) to Dec. 2025 (zł155 Mil).

PCC Rokita Other Current Liabilities Related Terms

PCC Rokita Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for PCC Rokita's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCC Rokita Other Current Liabilities Chart

PCC Rokita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 216.58 340.37 204.93 183.86 155.45

PCC Rokita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206.82 189.82 146.77 155.45 169.25
WAR:PCR
82GF Score
PCC Rokita SA WAR:PCR
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PCC Rokita Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of zł169 Mil mean?
PCC Rokita (WAR:PCR) has a Other Current Liabilities of zł169 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PCC Rokita.
Is PCC Rokita's Other Current Liabilities too high?
PCC Rokita's current Other Current Liabilities is zł169 Mil. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's Other Current Liabilities compare to DOW?
PCC Rokita's Other Current Liabilities of zł169 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Chemicals company?
A good Other Current Liabilities depends on the Chemicals industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PCC Rokita. PCC Rokita's current Other Current Liabilities is zł169 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current Other Current Liabilities is zł169 Mil. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current Other Current Liabilities is zł169 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PCC Rokita (WAR:PCR) Overvalued in 2026?

Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued. The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24. GuruFocus considers PCC Rokita to be Fairly Valued.

Key valuation signals for WAR:PCR:

  • Other Current Liabilities: zł169 Mil
  • GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PCC Rokita Business Description

Other Exchanges 229:Germany
Address ul. Sienkiewicza 4, Brzeg Dolny, POL, 56-120
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score

Get the complete analysis for WAR:PCR

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł69.50
Price
zł66.24
GF Value